Kilitch Drugs (India)191.45

+2.78 (+1.47%)

/

/

Kilitch Drugs (India) Share Price

191.45+2.78 (+1.47%)

+6.39% past 1 Year

Corporate filings & documents

Announcements

We are submitting herewith the scrutinizers report for the voting process of 34th Annual General Meeting of Kilitch Drugs India Limited

We are submitting herewith the scrutinizers report for the voting process of 34th Annual General Meeting of Kilitch Drugs India Limited

We are submitting herewith the proceeding of 34th Annual General Meeting

We are submitting herewith the proceeding of 34th Annual General Meeting

We are submitting herewith the monitoring agency report

We are submitting herewith the publication of extract of the financial results for the quarter ended 30th June 2026

Submission of financial results for the quarter ended 30th June 2026

Submission of financial results for the quarter ended 30th June 2026

We are submitting herewith the financial results for the quarter ended 30th June 2026

We are submitting herewith the financial results for the quarter ended 30th June 2026

Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter ended 30th June 2026

Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter ended 30th June 2026

We are submitting herewith the copy of the newspaper publication of extract of AGM Notice

We are submitting herewith the copy of the newspaper publication of extract of AGM Notice

We are submitting the copy of Physical intimation made to the shareholders whose email address was not registered

We are submitting the copy of Physical intimation made to the shareholders whose email address was not registered

We are submitting the intimation of Book Closure

We are submitting the intimation of Book Closure

We are submitting herewith the annual report for the FY 2025-26

We are submitting herewith the annual report for the FY 2025-26

We are hereby submitting the notice of Annual General Meeting schedule to be held on Thursday 27th August 2026

We are hereby submitting the notice of Annual General Meeting schedule to be held on Thursday 27th August 2026

Outcome of board meeting is enclosed for ready reference

Outcome of board meeting is enclosed for ready reference

We are submitting herewith the certification under regulation 74(5) of SEBI (DP) Regulations

We are submitting herewith the certification under regulation 74(5) of SEBI (DP) Regulations

We are submitting herewith the intimation of Closure of window

We are submitting herewith the intimation of Closure of window

We are pleased to inform you that we have commenced the Nutraceutical Manufacturing Block of our new plant located at 24/2/1/1 Maldev Pen Raigad Maharashtra India today. i.e 17th June 2026

We are pleased to inform you that we have commenced the Nutraceutical Manufacturing Block of our new plant located at 24/2/1/1 Maldev Pen Raigad Maharashtra India today. i.e 17th June 2026

We are hereby submitting annual secretarial compliance report for the year ended 31st March 2026

We are submitting hereby copy of newspaper publication of the extract of financial results for the quarter ended 31st March 2026

We are submitting hereby copy of newspaper publication of the extract of financial results for the quarter ended 31st March 2026

We are hereby submitting audited standalone and consolidated financial results of the Company for the quarter ended 31st March 2026

We are hereby submitting audited standalone and consolidated financial results of the Company for the quarter ended 31st March 2026

We are hereby submitting audited standalone and consolidated financial results for the quarter ended 31st March 2026

We are hereby submitting audited standalone and consolidated financial results for the quarter ended 31st March 2026

We are hereby submitting the monitoring agency report for the quarter ended 31st March 2026

We are hereby submitting the monitoring agency report for the quarter ended 31st March 2026

Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 inter alia to consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and year ended 31st March 2026

Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 inter alia to consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and year ended 31st March 2026

We are hereby submitting certificate under regulation 74(5) of SEBI (DP) Regulations received from MUFG Intime India Private Limited RTA of the Company

We are hereby submitting certificate under regulation 74(5) of SEBI (DP) Regulations received from MUFG Intime India Private Limited RTA of the Company

Board approved the allotment of bonus equity shares in the ratio of 1:1

Closure of Trading Window

We hereby inform you that the Company has fixed Tuesday 24th March 2026 as record date in order to determine the number of shareholders entitled for bonus equity shares in the ratio of 1:1

We hereby inform you that the Company has fixed Tuesday 24th March 2026 as record date in order to determine the number of shareholders entitled for bonus equity shares in the ratio of 1:1

We are submitting herewith the Scrutinizers Report

We are submitting herewith the Scrutinizers Report

We hereby submit proceeding of EGM

Annual reports

Concalls & investor presentations

Jun 2024

ConcallPresentation

Jun 2023

ConcallPresentation

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator